MISC

2012年6月

[Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology
  • Maki Numajiri
  • ,
  • Jun Aoki
  • ,
  • Kazuhiko Iwahashi
  • ,
  • Fumihiko Fukamauchi
  • ,
  • Minoru Enomoto
  • ,
  • Eiji Yoshihara
  • ,
  • Ohshi Murayama
  • ,
  • Daisuke Nishizawa
  • ,
  • Kazutaka Ikeda
  • ,
  • Jun Ishigooka

32
3
開始ページ
161
終了ページ
3
記述言語
日本語
掲載種別
Scientific Journal

GSK-3beta codes for an enzyme which is a target for the action of mood stabilizers, lithium and possibly of valproic acid. The relationship between the polymorphisms (SNPs) of GSK-3beta-50T/C and -1727A/T and the effect of lithium was studied among 29 Japanese bipolar patients. It was shown that GSK-3beta-50T/C may be linked with the effect of lithium treatment. There is a significantly higher T-allele frequency in the lithium responders than non-responders (df = 1, chi2 = 6.971, 0.01 > P > 0.001; Yates' continuity correction). However, there is not a significant relationship between the polymorphisms of GSK-3beta-1727A/T and the effect of lithium treatment.

リンク情報
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/22834106
ID情報
  • ISSN : 1340-2544
  • PubMed ID : 22834106

エクスポート
BibTeX RIS